Last reviewed · How we verify
NCT04519593
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
NA trial testing Laparoscopic myomectomy with prior temporary uterine blood supply occlusion in Uterine Leiomyoma in 120 participants. Status unknown.
31 August 2022
Quick facts
| Lead sponsor | Mother and Child Clinic Saint-Petersburg |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 27 September 2020 |
| Primary completion | 31 August 2022 |
| Estimated completion | 1 November 2022 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- Laparoscopic myomectomy with prior temporary uterine blood supply occlusion
- Conventional laparoscopic myomectomy
Conditions studied
- Uterine Leiomyoma — all drugs for Uterine Leiomyoma →
- Uterine Fibroid — all drugs for Uterine Fibroid →
- Leiomyoma, Uterine — all drugs for Leiomyoma, Uterine →
- Myoma;Uterus — all drugs for Myoma;Uterus →
Sponsor
Mother and Child Clinic Saint-Petersburg
Who can join
18 and older, female only, with Uterine Leiomyoma or Uterine Fibroid. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A phase 3 multicenter unblinded randomized controlled trial comparing the temporary uterine blood supply occlusion with conventional approach during laparoscopic myomectomy in patients with uterine leiomyoma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04519593
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04519593 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mother and Child Clinic Saint-Petersburg
- Last refreshed: 14 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04519593.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing